Skip to content

Probiotics, illness and immunity in athletes

Lactobacillus fermentum supplementation, upper respiratory tract illness and athletes: A randomised controlled placebo trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000006943
Enrollment
100
Registered
2011-01-04
Start date
2008-06-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

1 capsule containing 1 billion per day of Lactobacillus fermentum PCC daily for 77 days

Sponsors

Probiomics Ltd
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion to the study will be determined according to physical activity levels with subjects required to be undertaking 3 exercise sessions weekly and a questionnaire to determine subject’s health in the previous month

Exclusion criteria

Use of immunomodulatory medications, asthma, GI illness

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 29, 2026